3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145–7.
5. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–76.
9. Benda C, Zhou T, Wang X, Tian W, Grillari J, Tse HF, et al. Urine as a source of stem cells. In: Weyand B, Dominici M, Hass R, Jacobs R, Kasper C, editors. Mesenchymal stem cells - basics and clinical application I. Berlin (Germanry): Springer Berlin Heidelberg; 2013. p. 19-32.
13. Madrid M, Lakshmipathy U, Zhang X, Bharti K, Wall DM, Sato Y, et al. Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee. Cytotherapy 2024;26:1382–99.
15. Sohn YD, Han JW, Yoon YS. Generation of induced pluripotent stem cells from somatic cells. Prog Mol Biol Transl Sci 2012;111:1–26.
20. Liu C, Ameen M, Himmati S, Thomas D, Sayed N. Generation of human iPSCs by protein reprogramming and stimulation of TLR3 signaling. Methods Mol Biol 2021;2239:153–62.
22. Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al. Generation of human induced pluripotent stem cells from urine samples. Nature Protoc 2012;7:2080–9.
26. Pavathuparambil Abdul Manaph N, Al-Hawwas M, Bobrovskaya L, Coates PT, Zhou XF. Urine-derived cells for human cell therapy. Stem Cell Res Ther 2018;9:189.
27. Shi Y, Liu G, Shantaram B, Atala A, Zhang Y. 736 Urine derived stem cells with high telomerase activity for cell based therapy in urology. J Urol 2012;187(4S): e302.
32. Andrews PW, Barbaric I, Benvenisty N, Draper JS, Ludwig T, Merkle FT, et al. The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells. Cell Stem Cell 2022;29:1624–36.